购物车
- 全部删除
- 您的购物车当前为空
Solanezumab (LY 2062430) 是一种优先结合可溶性淀粉样蛋白的单克隆抗体,可促进其从大脑中清除。Solanezumab 可用于研究阿尔茨海默症。
为众多的药物研发团队赋能,
让新药发现更简单!
Solanezumab (LY 2062430) 是一种优先结合可溶性淀粉样蛋白的单克隆抗体,可促进其从大脑中清除。Solanezumab 可用于研究阿尔茨海默症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,480 | 现货 | |
5 mg | ¥ 6,470 | 现货 | |
10 mg | ¥ 8,720 | 现货 | |
25 mg | ¥ 12,900 | 现货 | |
50 mg | ¥ 17,300 | 现货 | |
100 mg | ¥ 23,500 | 现货 |
产品描述 | Solanezumab (LY 2062430) is a monoclonal antibody that binds preferentially to soluble amyloid and promotes its clearance from the brain.Solanezumab is used in the study of Alzheimer's disease. |
别名 | 索拉珠单抗, LY2062430, LY 2062430 |
分子量 | 144.1 (kDa) |
CAS No. | 955085-14-0 |
存储 | store at low temperature | store at -20°C | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容